119 related articles for article (PubMed ID: 8240340)
21. Identification of the cellular mechanisms responsible for platelet-derived growth factor induced alterations in cytoplasmic vinculin distribution.
Herman B; Harrington MA; Olashaw NE; Pledger WJ
J Cell Physiol; 1986 Jan; 126(1):115-25. PubMed ID: 3080438
[TBL] [Abstract][Full Text] [Related]
22. Smooth muscle cell cycle and proliferation. Relationship between calcium influx and sarco-endoplasmic reticulum Ca2+ATPase regulation.
Magnier-Gaubil C; Herbert JM; Quarck R; Papp B; Corvazier E; Wuytack F; Lévy-Tolédano S; Enouf J
J Biol Chem; 1996 Nov; 271(44):27788-94. PubMed ID: 8910375
[TBL] [Abstract][Full Text] [Related]
23. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y
Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648
[TBL] [Abstract][Full Text] [Related]
24. Effects of platelet-derived growth factor and fibroblast growth factor on free intracellular calcium and mitogenesis.
Tucker RW; Chang DT; Meade-Cobun K
J Cell Biochem; 1989 Feb; 39(2):139-51. PubMed ID: 2715198
[TBL] [Abstract][Full Text] [Related]
25. Diltiazem inhibits DNA synthesis and Ca2+ uptake induced by insulin, IGF-I, and PDGF in vascular smooth muscle cells.
Fujiwara R; Hayashi T; Nakai T; Miyabo S
Cardiovasc Drugs Ther; 1994 Dec; 8(6):861-9. PubMed ID: 7742265
[TBL] [Abstract][Full Text] [Related]
26. Cytosolic Ca2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase.
Kobayashi S; Nishimura J; Kanaide H
J Biol Chem; 1994 Mar; 269(12):9011-8. PubMed ID: 7510699
[TBL] [Abstract][Full Text] [Related]
27. Growth factor-induced proliferation of human fibroblasts in serum-free culture depends on cell density and extracellular calcium concentration.
Betsholtz C; Westermark B
J Cell Physiol; 1984 Feb; 118(2):203-10. PubMed ID: 6607257
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor induces c-fos and c-myc mRNA in cultured rat aortic smooth muscle cells irrespective of intracellular Ca2+ levels.
Nishimura J; Kobayashi S; Shikasho T; Kanaide H
Jpn J Pharmacol; 1992; 58 Suppl 2():413P. PubMed ID: 1507636
[No Abstract] [Full Text] [Related]
29. Platelet-derived growth factor-mediated Ca2+ entry is blocked by antibodies to phosphatidylinositol 4,5-bisphosphate but does not involve heparin-sensitive inositol 1,4,5-trisphosphate receptors.
Huang CL; Takenawa T; Ives HE
J Biol Chem; 1991 Mar; 266(7):4045-8. PubMed ID: 1847912
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of BALB/c-3T3 cells in late G1: commitment to DNA synthesis controlled by somatomedin C.
Wharton W; Van Wyk JJ; Pledger WJ
J Cell Physiol; 1981 Apr; 107(1):31-9. PubMed ID: 7194350
[TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor stimulates Na+ influx in vascular smooth muscle cells.
Owen NE
Am J Physiol; 1984 Nov; 247(5 Pt 1):C501-5. PubMed ID: 6093577
[TBL] [Abstract][Full Text] [Related]
32. Effect of PDGF-AB heterodimer on a corneal epithelial cell line.
Knorr M; Hoppe J; Steuhl KP; Dartsch PC
Eur J Cell Biol; 1992 Apr; 57(2):202-9. PubMed ID: 1511697
[TBL] [Abstract][Full Text] [Related]
33. An increase in adenylate cyclase activity precedes DNA synthesis in cultured vascular smooth muscle cells.
Franks DJ; Plamondon J; Hamet P
J Cell Physiol; 1984 Apr; 119(1):41-5. PubMed ID: 6707101
[TBL] [Abstract][Full Text] [Related]
34. Platelet derived growth factor induces c-fos and c-myc mRNA in rat aortic smooth muscle cells in primary culture without elevation of intracellular Ca2+ concentration.
Nishimura J; Kobayashi S; Shikasho T; Kanaide H
Biochem Biophys Res Commun; 1992 Nov; 188(3):1198-204. PubMed ID: 1445353
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of Ca2+ channel blockers on Ca2+ transients and cell cycle progression in vascular smooth muscle cells.
Ahmed A; Kobayashi S; Shikasho T; Nishimura J; Kanaide H
Eur J Pharmacol; 1998 Mar; 344(2-3):323-31. PubMed ID: 9600669
[TBL] [Abstract][Full Text] [Related]
36. Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells.
Block LH; Emmons LR; Vogt E; Sachinidis A; Vetter W; Hoppe J
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2388-92. PubMed ID: 2928338
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Ca2+ transport by platelet-derived growth factor-BB in rat vascular smooth muscle cells.
Cirillo M; Quinn SJ; Romero JR; Canessa ML
Circ Res; 1993 Apr; 72(4):847-56. PubMed ID: 8443872
[TBL] [Abstract][Full Text] [Related]
38. High D-glucose stimulates the cell cycle from the G1 to the S and M phases, but has no competent effect on the G0 phase, in vascular smooth muscle cells.
Hiroishi G; Kobayashi S; Nishimura J; Inomata H; Kanaide H
Biochem Biophys Res Commun; 1995 Jun; 211(2):619-26. PubMed ID: 7540840
[TBL] [Abstract][Full Text] [Related]
39. Dual modes of action of platelet-derived growth factor and its inhibition by trichostatin-A for DNA synthesis in primary cultured smooth muscle cells of rat aorta.
Kimura M; Kimura I; Okabe M; Beppu T
Biol Pharm Bull; 1994 Mar; 17(3):399-402. PubMed ID: 8019505
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor causes sustained depletion of both inositol trisphosphate-sensitive and caffeine-sensitive intracellular calcium stores in vascular smooth muscle cells.
Lapidot SA; Phair RD
Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):44-51. PubMed ID: 7749815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
